{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:17:11Z","timestamp":1790806631287,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T00:00:00Z","timestamp":1521590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s11060-018-2834-4","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T09:48:49Z","timestamp":1521625729000},"page":"649-658","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Characteristics of time-activity curves obtained from dynamic 11C-methionine PET in common primary brain tumors"],"prefix":"10.1007","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2301-2680","authenticated-orcid":false,"given":"Yuichi","family":"Nomura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Ikegame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Muragaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Iwama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,21]]},"reference":[{"issue":"12","key":"2834_CR1","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1212\/WNL.32.12.1323","volume":"32","author":"G Chiro Di","year":"1982","unstructured":"Di Chiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, Patronas NJ, Kufta CV, Kessler RM, Johnston GS, Manning RG, Wolf AP (1982) Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 32(12):1323\u20131329","journal-title":"Neurology"},{"issue":"1","key":"2834_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1148\/radiology.195.1.7892494","volume":"195","author":"D Delbeke","year":"1995","unstructured":"Delbeke D, Meyerowitz C, Lapidus RL, Maciunas RJ, Jennings MT, Moots PL, Kessler RM (1995) Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195(1):47\u201352. \n                    https:\/\/doi.org\/10.1148\/radiology.195.1.7892494","journal-title":"Radiology"},{"issue":"2","key":"2834_CR3","first-page":"345","volume":"17","author":"T Ogawa","year":"1996","unstructured":"Ogawa T, Inugami A, Hatazawa J, Kanno I, Murakami M, Yasui N, Mineura K, Uemura K (1996) Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine. Am J Neuroradiol 17(2):345\u2013353","journal-title":"Am J Neuroradiol"},{"issue":"5","key":"2834_CR4","first-page":"778","volume":"39","author":"B Kaschten","year":"1998","unstructured":"Kaschten B, Stevenaert A, Sadzot B, Deprez M, Degueldre C, Del Fiore G, Luxen A, Reznik M (1998) Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and\/or carbon-11-methionine. J Nucl Med 39(5):778\u2013785","journal-title":"J Nucl Med"},{"issue":"5","key":"2834_CR5","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1212\/WNL.50.5.1316","volume":"50","author":"K Herholz","year":"1998","unstructured":"Herholz K, Holzer T, Bauer B, Schroder R, Voges J, Ernestus RI, Mendoza G, Weber-Luxenburger G, Lottgen J, Thiel A, Wienhard K, Heiss WD (1998) 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 50(5):1316\u20131322","journal-title":"Neurology"},{"issue":"5","key":"2834_CR6","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3171\/jns.2001.95.5.0746","volume":"95","author":"O Witte De","year":"2001","unstructured":"De Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, Salmon I, Brotchi J, Goldman S (2001) Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 95(5):746\u2013750. \n                    https:\/\/doi.org\/10.3171\/jns.2001.95.5.0746","journal-title":"J Neurosurg"},{"issue":"3","key":"2834_CR7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3171\/jns.2005.103.3.0498","volume":"103","author":"T Nariai","year":"2005","unstructured":"Nariai T, Tanaka Y, Wakimoto H, Aoyagi M, Tamaki M, Ishiwata K, Senda M, Ishii K, Hirakawa K, Ohno K (2005) Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg 103(3):498\u2013507. \n                    https:\/\/doi.org\/10.3171\/jns.2005.103.3.0498","journal-title":"J Neurosurg"},{"issue":"1","key":"2834_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00259-004-1598-6","volume":"32","author":"S Kim","year":"2005","unstructured":"Kim S, Chung JK, Im SH, Jeong JM, Lee DS, Kim DG, Jung HW, Lee MC (2005) 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging 32(1):52\u201359. \n                    https:\/\/doi.org\/10.1007\/s00259-004-1598-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"2834_CR9","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/neuonc\/now058","volume":"18","author":"NL Albert","year":"2016","unstructured":"Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, la Fougere C, Pope W, Law I, Arbizu J, Chamberlain MC, Vogelbaum M, Ellingson BM, Tonn JC (2016) Response assessment in neuro-oncology working group and European association for neuro-oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol 18(9):1199\u20131208. \n                    https:\/\/doi.org\/10.1093\/neuonc\/now058","journal-title":"Neuro Oncol"},{"issue":"7","key":"2834_CR10","first-page":"1432","volume":"27","author":"S Ceyssens","year":"2006","unstructured":"Ceyssens S, Van Laere K, de Groot T, Goffin J, Bormans G, Mortelmans L (2006) [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence. Am J Neuroradiol 27(7):1432\u20131437","journal-title":"Am J Neuroradiol"},{"issue":"10","key":"2834_CR11","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3174\/ajnr.A1242","volume":"29","author":"T Kato","year":"2008","unstructured":"Kato T, Shinoda J, Oka N, Miwa K, Nakayama N, Yano H, Maruyama T, Muragaki Y, Iwama T (2008) Analysis of 11C-methionine uptake in low-grade gliomas and correlation with proliferative activity. Am J Neuroradiol 29(10):1867\u20131871. \n                    https:\/\/doi.org\/10.3174\/ajnr.A1242","journal-title":"Am J Neuroradiol"},{"issue":"11","key":"2834_CR12","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00259-008-0847-5","volume":"35","author":"T Hatakeyama","year":"2008","unstructured":"Hatakeyama T, Kawai N, Nishiyama Y, Yamamoto Y, Sasakawa Y, Ichikawa T, Tamiya T (2008) 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma. Eur J Nucl Med Mol Imaging 35(11):2009\u20132017. \n                    https:\/\/doi.org\/10.1007\/s00259-008-0847-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"2834_CR13","doi-asserted-by":"publisher","first-page":"694","DOI":"10.2967\/jnumed.107.048082","volume":"49","author":"Y Terakawa","year":"2008","unstructured":"Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, Ohata K (2008) Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 49(5):694\u2013699. \n                    https:\/\/doi.org\/10.2967\/jnumed.107.048082","journal-title":"J Nucl Med"},{"issue":"1","key":"2834_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11060-012-0873-9","volume":"109","author":"T Aki","year":"2012","unstructured":"Aki T, Nakayama N, Yonezawa S, Takenaka S, Miwa K, Asano Y, Shinoda J, Yano H, Iwama T (2012) Evaluation of brain tumors using dynamic 11C-methionine-PET. J Neurooncol 109(1):115\u2013122. \n                    https:\/\/doi.org\/10.1007\/s11060-012-0873-9","journal-title":"J Neurooncol"},{"issue":"10","key":"2834_CR15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1097\/RLU.0b013e3182291b40","volume":"36","author":"ML Calcagni","year":"2011","unstructured":"Calcagni ML, Galli G, Giordano A, Taralli S, Anile C, Niesen A, Baum RP (2011) Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy. Clin Nucl Med 36(10):841\u2013847. \n                    https:\/\/doi.org\/10.1097\/RLU.0b013e3182291b40","journal-title":"Clin Nucl Med"},{"issue":"3","key":"2834_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/neuonc\/noq196","volume":"13","author":"M Kunz","year":"2011","unstructured":"Kunz M, Thon N, Eigenbrod S, Hartmann C, Egensperger R, Herms J, Geisler J, la Fougere C, Lutz J, Linn J, Kreth S, von Deimling A, Tonn JC, Kretzschmar HA, Popperl G, Kreth FW (2011) Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas. Neuro Oncol 13(3):307\u2013316. \n                    https:\/\/doi.org\/10.1093\/neuonc\/noq196","journal-title":"Neuro Oncol"},{"issue":"9","key":"2834_CR17","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1002\/ijc.29259","volume":"136","author":"N Thon","year":"2015","unstructured":"Thon N, Kunz M, Lemke L, Jansen NL, Eigenbrod S, Kreth S, Lutz J, Egensperger R, Giese A, Herms J, Weller M, Kretzschmar H, Tonn JC, la Fougere C, Kreth FW (2015) Dynamic 18F-FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses. Int J Cancer 136(9):2132\u20132145. \n                    https:\/\/doi.org\/10.1002\/ijc.29259","journal-title":"Int J Cancer"},{"issue":"9","key":"2834_CR18","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/neuonc\/nov088","volume":"17","author":"N Galldiks","year":"2015","unstructured":"Galldiks N, Stoffels G, Filss C, Rapp M, Blau T, Tscherpel C, Ceccon G, Dunkl V, Weinzierl M, Stoffel M, Sabel M, Fink GR, Shah NJ, Langen KJ (2015) The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma. Neuro Oncol 17(9):1293\u20131300. \n                    https:\/\/doi.org\/10.1093\/neuonc\/nov088","journal-title":"Neuro Oncol"},{"issue":"2","key":"2834_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/neuonc\/now149","volume":"19","author":"G Ceccon","year":"2017","unstructured":"Ceccon G, Lohmann P, Stoffels G, Judov N, Filss CP, Rapp M, Bauer E, Hamisch C, Ruge MI, Kocher M, Kuchelmeister K, Sellhaus B, Sabel M, Fink GR, Shah NJ, Langen KJ, Galldiks N (2017) Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy. Neuro Oncol 19(2):281\u2013288. \n                    https:\/\/doi.org\/10.1093\/neuonc\/now149","journal-title":"Neuro Oncol"},{"issue":"12","key":"2834_CR20","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1007\/s00259-007-0557-4","volume":"34","author":"G Moulin-Romsee","year":"2007","unstructured":"Moulin-Romsee G, D\u2019Hondt E, de Groot T, Goffin J, Sciot R, Mortelmans L, Menten J, Bormans G, Van Laere K (2007) Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine? Eur J Nucl Med Mol Imaging 34(12):2082\u20132087. \n                    https:\/\/doi.org\/10.1007\/s00259-007-0557-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"2834_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1148\/radiology.181.3.1947089","volume":"181","author":"I Kapouleas","year":"1991","unstructured":"Kapouleas I, Alavi A, Alves WM, Gur RE, Weiss DW (1991) Registration of three-dimensional MR and PET images of the human brain without markers. Radiology 181(3):731\u2013739. \n                    https:\/\/doi.org\/10.1148\/radiology.181.3.1947089","journal-title":"Radiology"},{"issue":"4","key":"2834_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00259-012-2295-5","volume":"40","author":"AW Glaudemans","year":"2013","unstructured":"Glaudemans AW, Enting RH, Heesters MA, Dierckx RA, van Rheenen RW, Walenkamp AM, Slart RH (2013) Value of 11C-methionine PET in imaging brain tumours and metastases. Eur J Nucl Med Mol Imaging 40(4):615\u2013635. \n                    https:\/\/doi.org\/10.1007\/s00259-012-2295-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"2834_CR23","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/neuonc\/nos259","volume":"14","author":"NL Jansen","year":"2012","unstructured":"Jansen NL, Schwartz C, Graute V, Eigenbrod S, Lutz J, Egensperger R, Popperl G, Kretzschmar HA, Cumming P, Bartenstein P, Tonn JC, Kreth FW, la Fougere C, Thon N (2012) Prediction of oligodendroglial histology and LOH 1p\/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas. Neuro Oncol 14(12):1473\u20131480. \n                    https:\/\/doi.org\/10.1093\/neuonc\/nos259","journal-title":"Neuro Oncol"},{"issue":"9","key":"2834_CR24","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/RLU.0b013e318262af48","volume":"37","author":"Y Okada","year":"2012","unstructured":"Okada Y, Nihashi T, Fujii M, Kato K, Okochi Y, Ando Y, Yamashita M, Maesawa S, Takebayashi S, Wakabayashi T, Naganawa S (2012) Differentiation of newly diagnosed glioblastoma multiforme and intracranial diffuse large B-cell Lymphoma using (11)C-methionine and (18)F-FDG PET. Clin Nucl Med 37(9):843\u2013849. \n                    https:\/\/doi.org\/10.1097\/RLU.0b013e318262af48","journal-title":"Clin Nucl Med"},{"issue":"37","key":"2834_CR25","doi-asserted-by":"publisher","first-page":"23629","DOI":"10.1074\/jbc.273.37.23629","volume":"273","author":"Y Kanai","year":"1998","unstructured":"Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H (1998) Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 273(37):23629\u201323632","journal-title":"J Biol Chem"},{"issue":"2","key":"2834_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10014-005-0188-z","volume":"22","author":"H Nawashiro","year":"2005","unstructured":"Nawashiro H, Otani N, Uozumi Y, Ooigawa H, Toyooka T, Suzuki T, Katoh H, Tsuzuki N, Ohnuki A, Shima K, Shinomiya N, Matsuo H, Kanai Y (2005) High expression of L-type amino acid transporter 1 in infiltrating glioma cells. Brain Tumor Pathol 22(2):89\u201391. \n                    https:\/\/doi.org\/10.1007\/s10014-005-0188-z","journal-title":"Brain Tumor Pathol"},{"issue":"2","key":"2834_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11060-010-0117-9","volume":"99","author":"S Okubo","year":"2010","unstructured":"Okubo S, Zhen HN, Kawai N, Nishiyama Y, Haba R, Tamiya T (2010) Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas. J Neurooncol 99(2):217\u2013225. \n                    https:\/\/doi.org\/10.1007\/s11060-010-0117-9","journal-title":"J Neurooncol"},{"issue":"8","key":"2834_CR28","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/j.ejrad.2011.04.009","volume":"81","author":"T Saito","year":"2012","unstructured":"Saito T, Yamasaki F, Kajiwara Y, Abe N, Akiyama Y, Kakuda T, Takeshima Y, Sugiyama K, Okada Y, Kurisu K (2012) Role of perfusion-weighted imaging at 3T in the histopathological differentiation between astrocytic and oligodendroglial tumors. Eur J Radiol 81(8):1863\u20131869. \n                    https:\/\/doi.org\/10.1016\/j.ejrad.2011.04.009","journal-title":"Eur J Radiol"},{"issue":"4","key":"2834_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4161\/cbt.23624","volume":"14","author":"IM Zitron","year":"2013","unstructured":"Zitron IM, Kamson DO, Kiousis S, Juhasz C, Mittal S (2013) In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1. Cancer Biol Ther 14(4):333\u2013339. \n                    https:\/\/doi.org\/10.4161\/cbt.23624","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"2834_CR30","first-page":"709","volume":"21","author":"R Shi","year":"2016","unstructured":"Shi R, Jiang T, Si L, Li M (2016) Correlations of magnetic resonance, perfusion-weighed imaging parameters and microvessel density in meningioma. J BUON 21(3):709\u2013713","journal-title":"J BUON"},{"issue":"2","key":"2834_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/02841850802616752","volume":"50","author":"W Liao","year":"2009","unstructured":"Liao W, Liu Y, Wang X, Jiang X, Tang B, Fang J, Chen C, Hu Z (2009) Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol 50(2):217\u2013225. \n                    https:\/\/doi.org\/10.1080\/02841850802616752","journal-title":"Acta Radiol"},{"key":"2834_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-017-3846-6","author":"A Verger","year":"2017","unstructured":"Verger A, Stoffels G, Bauer EK, Lohmann P, Blau T, Fink GR, Neumaier B, Shah NJ, Langen KJ, Galldiks N (2017) Static and dynamic 18F-FET PET for the characterization of gliomas defined by IDH and 1p\/19q status. Eur J Nucl Med Mol Imaging. \n                    https:\/\/doi.org\/10.1007\/s00259-017-3846-6","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-018-2834-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-2834-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-2834-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T20:46:12Z","timestamp":1553114772000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-018-2834-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,21]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["2834"],"URL":"https:\/\/doi.org\/10.1007\/s11060-018-2834-4","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,21]]},"assertion":[{"value":"7 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the research committee of Gifu University Hospital and Kizawa Memorial Hospital Foundation and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}